The Molecular Basis of Immunotherapy in Cancer Treatment
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 395
Special Issue Editor
2. Candiolo, C/o IRCCS, IIGM-Italian Institute for Genomic Medicine, Turin, Italy
3. Candiolo Cancer (IT), FPO-IRCCS, Candiolo Cancer Institute, Turin, Italy
Interests: cancer epigenetics; human genetics; stem cell; CRISPR/Cas9 system for gene knock-out and knock-in; cloning; TCGA data analysis; NGS data analysis
Special Issue Information
Dear Colleagues,
Immunotherapy has revolutionized cancer treatment, bringing hope for better results in many tumors, while further research and refining are needed to meet its limits. Immunotherapy uses the immune system's sophisticated molecular systems to target and eradicate cancer cells. The efficacy of these treatments is based on a thorough understanding of the immune system's components, the molecular biology of immune cell function, cancer cell evasion methods, and their interconnections. Immunotherapy works through a variety of processes, including immune checkpoints and T cell activation, tumor antigens and antigen presentation, CAR-T cell therapy, monoclonal antibodies, immune evasion mechanisms, cytokines, and immunomodulation. These therapies alter biological processes to defeat cancer's evasion strategies and restore the immune system's ability to attack the disease effectively. In this Special Issue, we intend to collect research on the molecular basis of immunotherapy and its challenges. We welcome original research, reviews, and perspective articles describing in vivo, in vitro, and in silico studies. We look forward to receiving your contributions.
Dr. Hassan Dastsooz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- cancer
- CAR-T cell therapy
- monoclonal antibodies
- immunomodulation
- cytokines
- immune evasion mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
